Steve Kearney is the Medical Director at SAS where he helps lead the organization’s focus on the future of digital health across health care, life sciences, government research and development divisions. An innovator in health outcomes and digital medicine, Dr. Kearney co-developed and implemented one of the first electronic disease registries at Duke Health while also offering the first web-based ambulatory medicine elective at UNC. Dr. Kearney then joined the medical outcomes group at Pfizer where he continued his practical, actionable approach to data and the patient journey. He focused on health outcome insights from electronic medical record migrations, early personal digital assistants, novel health software programs and the first large patient claims databases. Throughout his career, Dr. Kearney has been a trusted advisor on health policy for state and federal agencies.
The pandemic caused public health agencies and life sciences companies to scramble to find effective treatments. Exploring the efficacy of existing drugs to treat COVID, an example of what's known as drug repurposing, was an intense focus for Qais Hatim, a Data Scientist at the US Food and Drug Administration
The management of the COVID-19 vaccination program is one of the most complex tasks in modern history. Even without the added complications of administering the vaccine during a pandemic, the race to vaccinate the populations who need it most all while maintaining the necessary cold-storage protocols, meeting double dose requirements,
I was recently honored to share the stage with government and medical leaders to discuss ways to impact the nation’s opioid epidemic. Hosted by The Washington Post, this event included often spirited conversations on ways to solve this national crisis. As the medical director for SAS US Government, I have
The opioid epidemic continues to be one of the largest challenges facing the United States. In 2016, more than 42,000 Americans died from opioid overdoses, and that number continues to climb. Recent data shows that more than 130 people die every day in the United States after overdosing on opioids,
The headline from the Newark Star-Ledger tells the story: “N.J. drug overdose deaths in 2018 on a record-shattering pace.” The opioid crisis continues to grow in New Jersey. From July 1, 2016 to June 30, 2017, the state saw a 34.7 percent increase in the number of opioid-related deaths, a
A person in the United States dies every 15 minutes because of substance use disorder. The number has doubled in the past 10 years as the crisis continues to grow in severity, especially in rural areas with high unemployment. Using analytics to map the growth of opioid deaths shows the
